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The in vivo role of alveolar macrophages in the infections with 2009 pandemic H1N1 inﬂuenza virus is
not as yet known. Ferret study shows that alveolar macrophages are critical for lowering the risk of
severe outcomes in 2009 pandemic H1N1 inﬂuenza virus infections. Up to 40% of the infected ferrets
depleted of alveolar macrophages died, with elevated body temperature and major loss of body weight in
contrast to infected ferrets not depleted of alveolar macrophages. The higher viral titers in the lungs were
detected in infected ferrets depleted of alveolar macrophages than infected ferrets not depleted of
alveolar macrophages 5 days after infection. The inﬂammatory chemokines were induced at greater
levels in the lungs of infected ferrets depleted of alveolar macrophages than in those of infected ferrets
not depleted of alveolar macrophages. Our study implies that alveolar macrophages are important for
controlling the infections of 2009 pandemic H1N1 inﬂuenza virus.
& 2013 Elsevier Inc. All rights reserved.Introduction
Inﬂuenza virus belongs to Orthomyxoviridae family which
include inﬂuenza A, B, and C genera (Bouvier and Palese, 2008).
The genome of inﬂuenza virus is segmented negative-strand RNA
that requires RNA-dependent RNA polymerase to replicate. Inﬂu-
enza A virus is further subtyped based on the antigenicity of its
surface glycoproteins, the hemagglutinin (HA) and the neurami-
nidase (NA) and is responsible for human pandemics (Bouvier and
Palese, 2008). Inﬂuenza A virus has a broad spectrum of host
ranges including humans and animals such as birds, pigs, horses,
seals, mink, and whales (Webster et al., 1992). Most known
subtypes of inﬂuenza A viruses including 16 HA and 9 NA subtypes
are circulating in aquatic birds (Fouchier et al., 2005; Webster
et al., 1992).
Inﬂuenza A viruses are responsible for human pandemics.
During the 20th century, the devastating pandemic that claimed
over 50 million human lives was caused by avian-like H1N1
inﬂuenza virus in 1918 (Johnson and Mueller, 2002; Taubenberger
et al., 1997; Taubenberger et al., 2005), and the pandemics causedll rights reserved.
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.by the reassorted viruses between genes of avian and human
inﬂuenza viruses occurred in 1957 and 1968 (Kawaoka et al.,
1989; Scholtissek et al., 1978), The 1957 and 1968 pandemics were
caused by H2N2 and H3N2 inﬂuenza viruses. During the 21st
century, we experienced a pandemic caused by a swine-origin
H1N1 inﬂuenza virus in 2009. In April, 2009 a swine-origin H1N1
inﬂuenza virus that was antigenically distinct from the seasonal
H1N1 inﬂuenza virus was found in humans (CDC, 2009). After that,
the novel H1N1 inﬂuenza virus spread worldwide, resulting in the
declaration of a global pandemic by the World Health Organization
on 11 June, 2009. The clinical signs of most people infected with this
virus were mild, but young people and the immune-compromised
people with conditions such as asthma, diabetes, severe obesity, lung
problem and pregnancy suffered from severe clinical signs including
death (Jain et al., 2009). The genetic analysis of this virus shows that
it consists of a unique combination of genes from viruses that
circulated in pigs in North America, Europe, and Eurasia (Garten
et al., 2009). The NA and matrix (M) genes originated from viruses
that belong to the Eurasian swine genetic lineage, the HA, nucleo-
protein (NP), and nonstructural (NS) genes are derived from viruses
of classical swine lineage, and polymerase basic 2 (PB2), polymerase
basic 1 (PB1), and polymerase acidic (PA) genes are from the viruses
of swine triple reassortant lineage (Garten et al., 2009).
Macrophages are involved in maintaining the homeostasis of
organs, rendering host defense, and wound healing (Duan et al.,
2012; Murray andWynn, 2011). Macrophages are functionally plastic,
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external stimuli (Gordon and Martinez, 2010). The classically acti-
vated macrophages produce the inﬂammatory cytokines and che-
mokines and are involved in killing pathogens, while the
alternatively activated macrophages possess immunoregulatory
properties, inducing wound healing and modifying the extracellular
matrix by secretion of proteases and growth factors (Gordon and
Martinez, 2010). Macrophage precursors generated from the com-
mitted hematopoietic stem cells in the bone marrow are released
into the circulation as a form of monocytes and are seeded into
tissues throughout the body, becoming macrophages or dendritic
cells (Murray and Wynn, 2011). Alveolar macrophages reside in the
alveolar airspaces, and over 98% of the cells in the alveolar airspaces
are alveolar macrophages (9). In the lungs, they live in a quiescent
and immunosuppressive state that can exert pathogen phagocytosis
and T cell trafﬁcking in the early response of viral and bacterial
infection (33). The in vitro or in vivo studies imply that macrophages
are involved in pathogenesis and immune responses in inﬂuenza
virus infections (Gao et al., 2012; Kim et al., 2008; Osterlund et al.,
2010; Tate et al., 2010; Tumpey et al., 2005). The 2009 pandemic
H1N1 inﬂuenza virus triggered the weak induction of cytokines in
human macrophages and dendritic cells (Osterlund et al., 2010), andFig. 1. The depletion efﬁciency of alveolar macrophages and the inﬁltration of cells and b
were depleted of alveolar macrophages by treatment with clodronate-liposome for 7 day
07/2009). The BAL samples were treated with Wright staining to determine the depletio
the BAL samples collected from ferrets were stained with Wright reagent to enumerate
bacterial infections. Statistical analysis was performed between data of ferrets treated wi
in BAL samples from ferrets before infections a, cells from the untreated and uninfected
the uninfected ferrets treated with clodronate-liposome. (B) The depletion efﬁciency o
broncho-alveolar space of infected ferrets. (D) The inﬁltration bacteria in the broncho-athe infection of swine macrophageswith the 2009 pandemic H1N1
inﬂuenza virus strongly induced proinﬂammatory cytokines such as
interleukin (IL)-6, IL-8, IL-10, and tumor necrosis factor (TNF)-α (Gao
et al., 2012). An in vivo depletion study of alveolar macrophages in
mice showed that alveolar macrophages are important for control-
ling the infections with 1918 pandemic H1N1 or seasonal H3N2
inﬂuenza viruses (Tate et al., 2010; Tumpey et al., 2005). The
depletion of alveolar macrophages in a pig, a natural host of inﬂuenza
virus caused more severe disease than non-depleted infected pigs
with a seasonal H1N1 inﬂuenza virus (Kim et al., 2008).
Ferrets (Mustela putorius furo) have been used for studying the
pathogenesis caused by inﬂuenza viruses since they can show
clinical signs similar to humans infected with inﬂuenza viruses
(Belser et al., 2011a, 2011b; Kang et al., 2011; Kim et al., 2009;
Munster et al., 2009; Roberts et al., 2012; Seibert et al., 2010).
In ferrets infected with 2009 pandemic H1N1 inﬂuenza virus the
higher inﬂammatory cytokines including IL-6, interferon (IFN)-α,
and TNF-α were induced than in ferrets infected with seasonal
H1N1 inﬂuenza virus (Kang et al., 2011). Ferrets infected with
2009 pandemic H1N1 inﬂuenza virus suffered from more severe
disease than those infected with seasonal H1N1 inﬂuenza virus
(Munster et al., 2009).acteria in the broncho-alveolar space in the infected ferrets. Ferrets (n¼3 per group)
s before they were infected with 2009 pandemic H1N1 inﬂuenza virus (A/California/
n efﬁciency. After ferrets were infected with 2009 pandemic H1N1 inﬂuenza virus,
the inﬁltration cells in the lungs of ferrets or smeared on agar plate to determine
th clodronate-liposome and PBS-liposome. **Po0.001. (A) The cell pictures (200)
ferrets; b, cells from the uninfected ferrets treated with PBS-liposome; c, cells from
f alveolar macrophages in ferrets before infection. (C) The inﬁltrating cells in the
lveolar space of infected ferrets.
H.M. Kim et al. / Virology 444 (2013) 394–403396The current study investigated the role of alveolar macro-
phages in ferrets infected with 2009 pandemic H1N1 inﬂuenza
virus. We studied the clinical signs including mortality, the change
of body temperature, and body weights in ferrets depleted of
alveolar macrophages with clodronate-liposome and infected with
2009 pandemic H1N1 inﬂuenza virus. We also determined the
induction of cytokines and chemokines in the lungs of ferrets
infected with 2009 pandemic H1N1 inﬂuenza virus to explain the
underlying mechanism of disease severity of infected ferrets
depleted of alveolar macrophages.Results
Clodronate-liposome efﬁciently depletes alveolar macrophages in the
lungs of ferrets
We depleted the alveolar macrophages in ferrets using the
clodronate-liposome that causes apoptosis of macrophages before
ferrets were infected with 2009 pandemic H1N1 inﬂuenza virus.
We determined the depletion efﬁciency of alveolar macrophages
in ferrets with clodronate-liposome (Fig. 1A and B). When the cells
collected from the lungs of ferrets treated with clodronate-
liposome for 7 days were stained with Wright staining solution
the cells from untreated or PBS-liposome treated ferrets contained
many intact alveolar macrophages (Fig. 1A-a and A-b), while theFig. 2. The mortality, the change of body temperatures, and body weights, and clinical s
or PBS-liposome were i.n. infected with 2009 pandemic H1N1 inﬂuenza virus (A/Californ
of rectal body temperatures for 14 days (once per day) after infections. The clinical sco
statistical analysis was performed between data of infected ferrets treated with clodr
infected ferrets. (B) The change of body temperatures of infected ferrets. (C) The changcells from clodronate-liposome treated ferrets contained small
number of alveolar macrophages with much cell-disrupted debris
(Fig. 1A-c). We calculated the depletion efﬁciency of alveolar
macrophages in ferrets with clodronate-liposome by counting
the cell numbers compared to the number of alveolar macro-
phages from untreated ferrets (Fig. 1B). The treatment of ferrets
with clodronate-liposome resulted in about 81% depletion of
alveolar macrophages, while no depletion of alveolar macrophages
occurred in the infected ferrets treated with PBS-liposome, in the
non-treated infected ferrets, and in the non-treated uninfected
ferrets (Fig. 1B). To ﬁnd out the possible recruitment of cells such
as alveolar macrophages, lymphocytes, and neutrophils in the
lungs of ferrets infected with 2009 pandemic H1N1 inﬂuenza
virus, we enumerated the total cell number in the BAL samples
of infected ferrets at 5 days after infection (Fig. 1C). The number of
alveolar macrophages in the infected ferrets treated with
clodronate-liposome remained lower than that of control groups
including PBS-liposome treated infected ferrets, non-treated
infected ferrets, and non-treated uninfected ferrets (Fig. 1C),
whereas the number of lymphocytes and neutrophils was higher
in the infected ferrets treated with clodronate-liposome than that
in control groups such as PBS-liposome treated infected ferrets,
non-treated infected ferrets, and non-treated uninfected ferrets
(Fig. 1C). Lymphocyte and neutrophil counts in clodronate-
liposome treated ferrets were statistically different from those in
PBS-liposome treated ferrets (Fig. 1C). We also measured the totalcores of infected ferrets. Ferrets (n¼5 per group) treated with clodronate-liposome
ia/07/2009) and were monitored for deaths, the change of body weight, the change
res of infected ferrets were calculated as described in materials and methods. The
onate-liposome and PBS-liposome. *Po0.05; **Po0.001. (A) The survival rate of
e of body weights of infected ferrets. (D) The clinical scores of infected ferrets.
Fig. 3. The viral titers in the left cranial lung lobe of infected ferrets. Ferrets (n¼3
per group) treated with clodronate-liposome or PBS-liposome were i.n. infected
with 2009 pandemic H1N1 inﬂuenza virus (A/California/07/2009) and were
euthanized at 3 or 5 days after infection to collect the left cranial lobes of lungs.
The collected lung tissues were homogenized in PBS (pH 7.4) before the viral titers
were determined by log 10 EID50/ml. The statistical analysis was performed
between viral titers of infected ferrets treated with clodronate-liposome and PBS-
liposome. *Po0.05.
H.M. Kim et al. / Virology 444 (2013) 394–403 397bacterial number in BAL samples collected from ferrets at 5 days
after infection to ﬁnd out whether the depletion of alveolar
macrophages could affect the bacterial infection in the lungs of
ferrets (Fig. 1D). The number of bacteria (9.15104) in the lungs of
infected ferrets treated with clodronate-liposome was slightly
higher than that of bacteria in the lungs of control groups
including PBS-liposome treated infected ferrets (8.6104), non-
treated infected ferrets (8.5104), and non-treated uninfected
ferrets (8.7104) (Fig. 1D). Bacterial number in clodronate-
liposome treated ferrets was not statistically different from those
in PBS-liposome treated ferrets (Fig. 1D).
Alveolar macrophage-deﬁcient infected ferrets showed more severe
clinical signs than alveolar macrophage-intact infected ferrets
Ferrets treated with clodronate-liposome were infected with
2009 pandemic H1N1 inﬂuenza virus and were monitored for
survival rate, the change of body temperature, the change of body
weight, and clinical score (Fig. 2A–D). When we evaluated the
survival rate the alveolar macrophage-deﬁcient infected ferrets
showed 60% of survival rate, while control groups such as PBS-
liposome treated infected ferrets, non-treated infected ferrets, and
non-treated uninfected ferrets showed 100% of survival rate
(Fig. 2A). Survival rate in clodronate-liposome treated ferrets was
statistically different from those in PBS-liposome treated ferrets
(Fig. 2A). When we measured the rectal temperature the infected
ferrets treated with clodronate-liposome showed higher body
temperature than control groups. The peak temperature of
infected ferrets treated with clodronate-liposome was 39 1C at
6 days after infection, and that of infected ferrets treated with PBS-
liposome was 38.6 1C at 6 days after infection (Fig. 2B). Body
temperature of non-treated infected ferrets was 38.7 1C at 6 days
after infection, and that of non-treated uninfected ferrets was
37.6 1C at 6 days after infection (Fig. 2B). Body temperature in
clodronate-liposome treated ferrets was statistically different from
those in PBS-liposome treated ferrets (Fig. 2B). The infected ferrets
treated with clodronate-liposome suffered from more marked
weight loss than those treated with PBS-liposome and untreated
infected ferrets (Fig. 2C). The mean body weight of infected ferrets
treated with clodronate-liposome was about 77% of original
weight at 10 days after infection, but that of infected ferrets
treated with PBS-liposome was 82.5% of original weight at 10
days after infection (Fig. 2C). The mean body weight of non-
treated infected ferrets was 82.3% at 10 days after infection, and
that of non-treated uninfected ferrets was 105.5% at 10 days after
infection (Fig. 2C). Body-weight loss in clodronate-liposome trea-
ted ferrets was statistically different from those in PBS-liposome
treated ferrets (Fig. 2A). The clinical scores were recorded based on
activity and respiratory clinical signs of infected ferrets (Fig. 2D).
The infected ferrets treated with clodronate-liposome showed
higher clinical scores than those treated with control groups
including PBS-liposome treated and infected ferrets. The sum of
clinical scores of infected ferrets treated with clodronate-liposome
and PBS-liposome was 10 and 1 at 8 days after infection,
respectively (Fig. 2D). The sum of clinical scores of non-treated
infected ferrets and non-treated uninfected ferrets was 2 and 0 at
8 days after infection (Fig. 2D). When we studied viral titers in the
lungs of ferrets the lungs of infected ferrets treated with
clodronate-liposome contained higher viral titers than those of
infected ferrets treated with PBS-liposome or untreated at 5 days
after infection. The mean viral titer in the lungs of infected ferrets
treated with clodronate-liposome was 6.75 EID50/ml, whereas that
of infected ferrets treated with PBS-liposome was 4.50 EID50/ml
(Fig. 3). The mean viral titer in the lungs of non-treated infected
ferrets was 4.75 EID50/ml, and that in the lungs of non-treated
uninfected ferrets was less than 1.0 EID50/ml (Fig. 3).Alveolar macrophage-deﬁcient infected ferrets showed greater
pathological damage to the lung than alveolar macrophage-intact
infected ferrets
We compared the pathological damage to the lungs of infected
ferrets treated with clodronate-liposome with that of control
groups including the infected ferrets treated with PBS-liposome.
The gross legion of lungs of infected ferrets treated with
clodronate-liposome showed pulmonary consolidation on the
dorsal right caudal area and the dorsal right caudal area at 3 days
after infection (Fig. 4A e-1 and e-2) and the pulmonary consolida-
tion on the dorsal left cranial and ventral left cranial area and
dorsal left cranial and ventral left cranial area at 5 days after
infection (Fig. 4A f-1 and f-2), while that of lungs of infected ferrets
treated with PBS-liposome showed mild pneumonia compared to
those of infected ferrets treated with clodronate-liposome (Fig. 4A
c-1, c-2, d-1, and d-2). The gross lesion of lungs of non-treated
infected ferrets was similar to that of infected ferrets treated PBS-
liposome (Fig. 4A g-1, g-2, h-1, and h-2), and that of lungs of non-
treated uninfected ferrets not showing any pneumonia (Fig. 4A a-1,
a-2, b-1, and b-2).
The gross lesion percentage of lungs showing pneumonia was
also higher in infected ferrets treated with clodronate-liposome
than that in infected ferrets treated with PBS-liposome. The
percentage showing pneumonia lesion of lungs of infected ferrets
treated with clodronate-liposome was 30 at 5 days after infection,
while that of lungs infected ferrets treated with PBS-liposome was
12 at 5 days after infection (Fig. 4B). The percentage showing
pneumonia lesion of lungs of non-treated infected ferrets was 15
at 5 days after infection and that of lungs non-treated uninfected
ferrets was 0 at 5 days after infection (Fig. 4B).
The staining of lung tissues with H&E also showed that the lung
tissues of infected ferrets treated with clodronate-liposome con-
tained more severe damage compared to those of infected ferrets
treated with PBS-liposome. The inﬁltrated inﬂammatory cells were
Fig. 4. The gross lesion and pneumonia percentage of lungs of infected ferrets treated with clodronate-liposome. Ferrets (n¼3 per group) treated with chlodronate-liposome
or PBS-liposome were i.n. infected with 2009 pandemic H1N1 inﬂuenza virus (A/California/07/2009) and were euthanized at 3 or 5 days to collect lungs. We showed one
ferret's lung per group since the others are similar in the group. The gross appearance of lungs was taken a picture (A). (a-1 and a-2) The lungs of untreated and uninfected
ferrets. (b-1 and b-2) The lungs of clodronate-liposome treated and uninfected ferrets. (c-1 and c-2) The lungs of PBS-liposome treated and infected ferrets at 3 days after
infection. (d-1 and d-2) the lungs of PBS-liposome treated and infected ferrets at 5 days after infection. (e-1 and e-2) The lungs of clodroante-liposome treated and infected
ferrets at 3 days after infection. (f-1 and f-2) the lungs of clodroante-liposome treated and infected ferrets at 5 days after infection. (g-1 and g-2) The lungs of untreated and
infected ferrets at 3 days after infection. (h-1 and h-2) The lungs of untreated and infected ferrets at 5 days after infection. (B) The surface-area percentage showing
pneumonia lesion out of whole lungs of ferrets (n¼3 per group) on 3 and 5 days after infection was measured. The statistical analysis was performed between percentage of
lungs showing pneumonia of infected ferrets treated with clodronate-liposome and PBS-liposome. nnPo0.001.
Fig. 5. The histopathological change in the left cranial lung lobe of infected ferrets. Ferrets (n¼3 per group) treated with clodronate-liposome or PBS-liposome were i.n.
infected with 2009 pandemic H1N1 inﬂuenza virus (A/California/07/2009) and were euthanized at 3 or 5 days to collect lungs. The collected lungs were stained with H&E
and were taken a picture (400). (a-1) Bronchus of untreated and uninfected ferret. (a-2) Bronchus of clodronate-liposome treated and uninfected ferret. (a-3) Bronchus of
PBS-liposome treated and infected ferrets at 3 days after infection. (a-4) Bronchus of PBS-liposome treated and infected ferrets at 5 days after infection.
H.M. Kim et al. / Virology 444 (2013) 394–403398more in the bronchial tissues of infected ferrets treated with
clodronate-liposome (Fig. 5a-5 and a-6) than in those of infected
with treated with PBS-liposome (Fig. 5a3 and a-4). The lumen of
bronchioles of infected ferrets treated with clodronate-liposome
(Fig. 5b-5 and b-6) contained more mucus and inﬂammatory cellsthan that of bronchioles of infected ferrets treated with PBS-liposome
(Fig. 5b-3 and b-4). The alveolar space of lungs of ferrets treated with
clodronate-liposome was ﬁlled with lots of inﬁltrated inﬂammatory
cells such lymphocytes and macrophages (Fig. 5c-5 and c-6), but that
of lungs of ferrets treated with PBS-liposome was inﬁltrated with few
Fig. 6. The antigen staining in the left cranial lung lobe of infected ferrets. The alveolar tissues from ferrets of Fig. 5 were stained with mouse inﬂuenza A virus anti-
nucleoprotein antibody, biotin-labeled goat anti-mouse immunoglobulin, VECTASTAIN ABC-AP, and Vector red alkaline phosphatase substrate (Vector, USA). We did not
show the pictures of bronchi and bronchioles of ferrets since no antigen was detected in these tissues. Arrow: positive staining. (a) Alveolar tissue of untreated and
uninfected ferrets. (b) Alveolar tissue of PBS-liposome treated and infected ferrets at 3 days after infection. (c) Alveolar tissue of PBS-liposome treated and infected ferrets at
5 days after infection. (d) Alveolar tissue of clodronate-liposome treated and infected ferrets at 3 days after infection. (e) Alveolar tissue of clodronate-liposome treated and
infected ferrets at 5 days after infection.
H.M. Kim et al. / Virology 444 (2013) 394–403 399number of inﬂammatory cells (Fig. 5c-3 and c-4). Bronchi, bronch-
ioles, and alveoli of uninfected ferrets did not show the accumulation
of inﬂammatory cells (Fig. 5a-1 a-2, b-1, b-2, c-1, and c-2).
When the viral antigens were detected with inﬂuenza NP
speciﬁc antibody the alveolar cells of lungs of infected ferrets
treated with clodronate-liposome (Fig. 6d and e) contained higher
number of positively stained cells than those of infected ferrets
treated with PBS-liposome (Fig. 6b and c). Pneumocytes were
dominantly infected (Fig. 6d and e). Alveolar cells of non-treated
uninfected ferret were not stained (Fig. 6a). Antigens were not
detected in bronchi and bronchioles (data not shown).Chemokines, not cytokines were induced higher in the lungs of
alveolar macrophage-deﬁcient infected ferrets than in those of
alveolar macrophage-intact infected ferrets
It has been suggested that the inﬂammatory responses may
contribute to pathogenicity caused by inﬂuenza virus infection.
We quantiﬁed the mRNA of cytokines and chemokines induced in
the lungs of ferrets. The cytokine induced were similar in the lungs
between infected ferrets treated with clodronate-liposome and
infected ferrets treated with PBS-liposome with the exception of
IL-6 and IFN-γ (Fig. 7A), but the chemokines were induced higher
in the lungs of ferrets treated with clodronate-liposome than in
those of ferrets treated with PBS-liposome (Fig. 7B). Cytokine s,
IL-6 (1.9-fold increase on 5 days p.i.) and IFN-γ(1.9-fold increase on
3 days p.i.) were induced more in the lungs of infected ferrets
treated with clodronate-liposome than in those of infected ferrets
treated with PBS-liposome (Fig. 7A). Chemokines, CCL8 that is
chemotactic for and activates many different immune cells includ-
ing mast cells, eosinophils and basophils, CCL11 that selectively
recruits eosinophils, CXCL9 that attracts T lymphocytes, CXCL10
that is chemotactic for monocytes, macrophages, T cells, NK cells,
and dendritic cells, and CXCL11 that is chemotactic for activated T
lymphocytes, were induced higher in the lungs of ferrets treated
with clodronate-liposome than in those of ferrets treated with
PBS-liposome. The induction of cytokines and chemokines in thelungs of clodronate-liposome treated infected ferrets was similar
to that in the lungs of non-treated infected ferrets (Fig. 7A and B).Discussion
Swine-origin pandemic H1N1 inﬂuenza occurred in 2009 and
caused severe disease in humans. The information on the in vivo
role of alveolar macrophages that constitutively reside in alveolar
space of lungs of humans and animals against 2009 pandemic
H1N1 inﬂuenza virus is limited. We studied the role of alveolar
macrophages in ferrets by treatment with clodronate-liposome to
trigger apoptosis of alveolar macrophages. Ferrets depleted of
alveolar macrophages and infected with 2009 pandemic H1N1
inﬂuenza virus suffered from more severe clinical signs than those
containing intact alveolar macrophages.
We showed that the depletion of alveolar macrophages in ferrets
by clodronate-liposome before infection with 2009 pandemic H1N1
inﬂuenza virus resulted in up to 40% mortality, while no mortality of
control infected ferrets whose alveolar macrophages were not
depleted was observed. In addition, the higher body temperatures,
greater reduction of body weights, and higher viral titers in the lungs
of infected ferrets depleted of alveolar macrophages were detected
than in those of infected intact ferrets. The previous studies of the
in vivo role of alveolar macrophages using inﬂuenza-infected mouse
and pig models similarly showed that the depletion of alveolar
macrophages using clodronate-liposome could lead to higher mortal-
ity and more increased clinical signs including reduced body weight
than inﬂuenza-infected animals that were not depleted of alveolar
macrophages (Kim et al., 2008; Tate et al., 2010; Tumpey et al., 2005).
When mice depleted of alveolar macrophages by clodronate-liposome
were infected with 1918 HA/NA:Tx/91 inﬂuenza virus the uncontrolled
virus growth and the higher mortality were observed (Tumpey et al.,
2005). Another study showed that different pathogenicity was
observed in mice depleted of alveolar macrophages and infected with
two strains of inﬂuenza viruses, A/PR/8/34 (H1N1) and BJx109 (H3N2)
(Tate et al., 2010). Depletion of alveolar macrophages in the air
ways by clodronate-liposome resulted in the severe pneumonia in
Fig. 7. Quantiﬁcation of cytokine and chemokine mRNA induced in the left cranial lung lobe of infected ferrets treated with clodronate-liposome. Ferrets (n¼3 per group)
treated with chlodronate-liposome or PBS-liposome were i.n. infected with 2009 pandemic H1N1 inﬂuenza virus (A/California/07/2009) and were euthanized at 3 or 5 days
to collect lungs. The induced mRNAwas quantiﬁed by real-time PCR using primers speciﬁc for ferret’s cytokines and chemokines. Statistical analysis was performed between
data of ferrets treated with clodronate-liposome and PBS-liposome. *Po0.05, **Po0.001. (A) Cytokines; (B) Chemokines.
H.M. Kim et al. / Virology 444 (2013) 394–403400BJx109-infected mice, while the depletion of alveolar macrophages did
not affect disease severity in A/PR/8/34 (H1N1)-infected mice. Our
previous study using an inﬂuenza virus-natural host, a pig, suggested
that alveolar macrophages are critical for controlling a seasonal
inﬂuenza virus (H1N1). The infected pigs depleted of alveolar macro-
phages by clodronate-liposome had 40% mortality (Kim et al., 2008).
The severe pathogenicity of clodronate-liposome treated ferrets which
were infected with 2009 pandemic H1N1 inﬂuenza virus may be also
partially due to the depletion of dendritic cells (DCs) since mice which
were i.t. treated with clodronate-liposome resulted in depletion of
alveolar macrophages and DCs (Bosio and Dow, 2005; McGill et al.,
2008).
Meanwhile, the previous studies on pathogenicity of 2009
pandemic H1N1 inﬂuenza virus using ferrets not depleted of
alveolar macrophages showed that the infected ferrets did not
die even though this virus caused more severe disease than
seasonal H1N1 inﬂuenza virus (Itoh et al., 2009; Kang et al.,
2011; Munster et al., 2009). Ferrets infected with 2009 pandemic
H1N1 inﬂuenza virus displayed higher body temperatures, greater
reduction in body weight, and higher viral titers in trachea and
lungs than those infected with seasonal H1N1 inﬂuenza virus
(Kang et al., 2011). Ferrets infected with 2009 pandemic H1N1
inﬂuenza virus showed more extensive virus replication in the
respiratory tracts than a seasonal H1N1 inﬂuenza virus. The
replication of 2009 pandemic H1N1 inﬂuenza virus occurred in
the tracheae, bronchi, and bronchioles, but that of seasonal H1N1
inﬂuenza virus was limited to the nasal cavity of ferrets (Munsteret al., 2009). The pathogenesis study using the pregnant mice also
showed that 2009 pandemic H1N1 inﬂuenza virus could cause
more severe diseases than seasonal H1N1 inﬂuenza virus (Kim
et al., 2012).
We showed that the viral titers in the lungs of clodronate-
liposome treated ferrets was higher than those in the lungs of PBS-
liposome treated ferret on 5 days p.i., but that no difference in the
viral titers in the lungs of ferrets was observed on 3 days p.i. The
similar viral titers in the lungs of ferrets on 3 days p.i. suggest that
alveolar macrophages may not be involved in inhibiting inﬂuenza
virus infection in the lungs of ferrets.
Our results showed that the number of bacteria in the lungs of
infected ferrets treated with clodronate-liposome was slightly
higher than that of bacteria in the lungs of control groups
including PBS-liposome treated and infected ferrets without
statistical signiﬁcance. Bacterial species was not identiﬁed in this
study since no signiﬁcant difference was observed in the both
groups of ferrets. The previous study on the cystic ﬁbrosis reported
that bacteria such as Staphylococcus, Bacillus, Enterococcus and
Streptococcus species were dominantly detected in BAL samples in
the ferrets (Sun et al., 2010).
Our study showed that chemokines such as CCL8, CCL11, CCL17,
CXCL19, CXCL10, and CXCL11 involved in recruiting the inﬂamma-
tory cells were induced higher in the lungs of infected ferrets treated
with clodronate-liposome than in those of infected ferrets treated
with PBS-liposome. The inﬁltration of many inﬂammatory cells
in the lungs of infected ferrets treated with clodronate-liposome
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be inﬂuenced by the increased induction of chemokine genes.
The previous studies showed that the inﬂammatory responses
could contribute to the pathogenicity of inﬂuenza viruses (Baskin
et al., 2009; Cameron et al., 2008). Macaques infected with lethal
H5N1 inﬂuenza virus suffered from the severe disease and showed
the marked elevation of genes related to interferons, inﬂammatory,
and innate immunity in the lungs (Baskin et al., 2009). The lungs
of ferrets infected with lethal H5N1 inﬂuenza virus were also
elevated with genes related to interferon responses and chemokines
(Cameron et al., 2008).
In conclusion, our study showed that alveolar macrophages are
important in defending a ferret, an important animal model for
human inﬂuenza from the infections by 2009 pandemic H1N1
inﬂuenza virus.Materials and methods
Virus
Swine-origin 2009 pandemic H1N1 inﬂuenza virus (A/California/
07/2009) was kindly provided byWorld Health Organization (WHO)-
collaborating center CDC (USA Centers for Disease Control and
Prevention) and propagated in the amniotic cavities of 10-day-old
hens' eggs prior to being used for the study.Animals
About 7-to-8-week-old ferrets obtained from Path valley farm
(Spring Run, PA, USA) were serologically negative to the human
inﬂuenza viruses, 2009 pandemic H1N1, H3N2, or human B virus
when their sera were tested by hemagglutination-inhibition (HI)
assay with those viruses and 0.5% turkey red blood cells. All animal
experiments were performed at the biosafety level 3 (BSL-3)
facility approved by Korean government.Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
animals of Korean veterinary quarantine and service. The protocol
(2010-3-12) was approved by Committee on the Ethics of Animal
Experiments of Chungnam National University.Depletion of alveolar macrophages in the ferrets' lungs
We used liposome-encapsulated dichloromethylene dipho-
sphonate (MDPCL2) (clodronate-liposome) (1.9–2.0 g/10 ml) that
was cytotoxic to alveolar macrophages (Van Rooijen, 1989) to
deplete alveolar macrophages in the lungs of ferrets in vivo.
Phosphate buffered solution (PBS)-encapsulated liposome (PBS-
liposome) was used as a control. The clodronate-liposome and
PBS-liposome were obtained from Dr. Nico van Rooijen at Depart-
ment of Cell Biology and Immunology, Free University, The Nether-
lands. Ferrets were intramuscularly (i.m.) anesthetized with Zoletil
(2 mg/kg) (Virbac Laboratories, Carros, France) and intratracheally
(i.t.) administered 0.5 ml of clodronate-liposome or PBS-liposome
for 7 days (once per day) before ferrets were infected with 0.5 ml
of 106 TCID50 of 2009 pandemic H1N1 inﬂuenza virus (A/Califor-
nia/07/2009), which was passaged 5 times in eggs. When we tried
intranasal administration of clodronate-liposome to deplete alveo-
lar macrophages in ferrets, we were not successful.Determination of depletion efﬁciency of alveolar macrophages in the
lungs of ferrets
We studied the depletion efﬁciency of alveolar macrophages
with clodronate-liposome in the lungs of ferrets (n¼3 per group)
by counting cells in bronchoalveolar lavage (BAL) samples. Ferrets
i.t. administered 0.5 ml of clodronate-liposome or PBS-liposome
for 7 days were euthanized with a high doses of Zoletil, and the
lungs with respiratory tracts (trachea and bronchus) were col-
lected from the ferrets before they were lavaged with 50 ml of PBS
(pH 7.4). The lavaged samples were centrifuged at 800g for 10 min
to spin down cells and the collected cells were re-suspended with
5 ml of PBS (pH 7.4). One hundred microliter of the re-suspended
cells was cytospined for Wright staining for differentiating cells.
The cytospined cells were allowed to air dry on the slide glass and
were ﬁxed by immersing them in methanol for 5 min before
Wright staining solution (Muto Pure Chemicals Co., Tokyo, Japan)
was dropped on the top of cells on the glass slide. The slide was
incubated for 2 min, and then Wright staining buffer was dropped
on before 5-min incubation at room temperature. The glass slide
was rinsed with the distilled water and then cells were counted
under a light microscope.
Cell was differentiated by its morphology, nuclear morphology,
and cytoplasmic granulation based on the counted 1000 cells in
random ﬁelds of view under the light microscope.
Counting bacteria in BAL samples
The BAL samples from infected ferrets (n¼3 per group) treated
with clodronate-liposome and PBS-liposome at 5 days after infec-
tion were tested for bacterial infection. The serial 10-fold dilutions
of BAL samples in PBS (pH 7.4) were transferred to a MacConkey
agar plate, a tryptic soy agar plate, or blood agar. The number of
bacterial colonies was counted at 72 h after incubation (37 1C).
Studying the clinical signs in the infected ferrets
Ferrets (n¼5 per group) depleted of alveolar macrophages by
clodronate-liposome or control ferrets administered with PBS-
liposome were i.n. infected with 106 TCID50 of 2009 pandemic
H1N1 inﬂuenza virus (A/California/07/2009). Respiratory signs and
mortality in the infected ferrets were observed daily, and body
weight and rectal temperature were measured for 14 days after
infection.
Measurement of clinical scores of infected ferrets
Ferrets (n¼5 per group) treated with clodronate-liposome or
PBS-liposome were i.n. infected with 106 TCID50 of 2009 pandemic
H1N1 inﬂuenza virus (A/California/07/2009). The clinical signs were
observed for 14 days after infection. Clinical scores were the sum of
activity and respiratory signs. The activity was graded as follows:
0 representing normal activity, 1 representing calm demeanor, and
2 representing depression and loss of interest in play. The respiratory
signs were graded as follows: 0 representing the normal state,
1 representing occasional sneezing and serous nose exudates, and
2 representing frequent sneezing, coughing, and mucosal nose
exudates.
Viral titration in the lungs of infected ferrets
One-gram parts of the left lung cranial lobes of ferrets (n¼3 per
group) infected with 106 TCID50 of 2009 pandemic H1N1 inﬂuenza
virus (A/California/07/2009) at 3 and 5 days post inoculation (p.i.)
were homogenized using homogenizer (Daihan Co., Seoul, Korea)
and frozen and thawed three times in 1 ml of PBS (pH 7.4)
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Louis, MO). The samples were serially 10-fold diluted in PBS (pH 7.4)
and each diluted sample was inoculated into 10-day-old hens' eggs.
The infection of virus in the inoculated eggs was determined by
hemagglutination (HA) assay. Viral titers were determined by
log 10 EID50/ml as described (Reed and Muench, 1938). We selected
the left cranial lobes of ferrets' lungs since the pathological legion is
severer than other lobes to measure the viral titers, and collected
tissues showing lesions on the left cranial lobes.Histopathological staining
The ferrets (n¼3 per group) infected with 106 TCID50 of 2009
pandemic H1N1 inﬂuenza virus (A/California/07/2009) were
euthanized with high doses of Zoletil at 3 and 5 days p.i., and
were thoroughly exsanguinated before the left cranial lobes of
lungs were collected within biosafety cabinet (BSC). The lung
tissues were ﬁxed by submerging them in the 10% neutral buffered
formalin and embedding in parafﬁn. Five-micrometer sections
were carried out and stained with hematoxylin and eosin (H&E)
as described (Bancroft and Stevens, 1996). The stained tissues were
evaluated under an Olympus DP70 microscope (Olympus Corpora-
tion, Tokyo, Japan).Table 1
Ferret's cytokine primers for quantitative real-time PCR.
cytokine Forward primer Reverse primer
IL-1a ACCCACTTCATGAGGACTGC TGCTACTGATCTGGGCTTCA
IL-1β GGACTGCAAATTCCAGGACATAA TTGGTTCACACTAGTTCCGTTGA
IL2 CTTCGCAAACAGTGCACCTA GCCTTCTTGGGCATGTAGAA
IL-4 TCACCGGCACTTTCATCCA TTCTCGCTGTGAGGATGTTCA
IL 5 GGGGAGGCTGTGGATAAACT CAACTTTCCGGTGTCCACTC
IL-6 AGTGGCTGAAACACGTAACAATTC ATGGCCCTCAGGCTGAACT
IL-8 AAGCAGGAAAACTGCCAAGAGA GCCAGAAGAAACCTGACCAAAG
IL10 CCTGTCGGAGATGATCCAGT CAAGCTCACTCATGGCTTTG
IL 11 CTGAGCCTGTGGCCAGATA GGGAATCCAGGTTGTGGTC
IL12β CACCAGCAGCTTCTTCATCA AGGTCTTGTCCACGCAGAGT
IL 13 TGGTTGACTGTGGTCATTGC GATGCCTGATTCTGGGTGAT
IL-16 GGGGAGCGGATCTAGAAAAC CGAGGAGGAGTTCAGGTCAG
IL17 CCTCAGCATGTGAAGGTCAA AACCAGGATCTCTTGCTGGA
IL 18 GAGGATATGCCCGATTCTGA ATCATGGCCTGGAACACTTC
TNF-a CCAGATGGCCTCCAACTAATCA GGCTTGTCACTTGGAGTTCGA
IFN-γ TCAAAGTGATGAATGATCTCTCACC GCCGGGAAACACACTGTGAC
Table 2
Ferret's chemokine primers for quantitative real-time PCR.
Chemokine Forward primer
CCL2 GCTCCCTATTCACTTGCTGTTTC
CCL 4 TGTGACCGTCCTTTCTCTCC
CCL5 GCTGCTTTGCCTACATTTCC
CCL 7 TATCTCAACCACCTGCTGCT
CCL8 CATCCCAATTACCTGCTGCT
CCL 11 AGGTCTCCGCAGCACTTCT
CCL 17 CGGGAGTGCTGCCTAGAGTA
CCL21 TCAGGCAGAGCTATGTGCAG
CCL22 ACTGCACTCCTGGTTGTCCT
CCL 23 ACGAATTCGATGTGCAAACA
CXCL5 GAGCTGCGTTGTGTGTGTTT
CXCL9 GGTGGTGTTCCTCTTTTGTTGAGT
CXCL10 CTTTGAACCAAAGTGCTGTTCTTA
CXCL 11 AGAGGACGCTGTCTTTGCAT
CXCL12 ACAGATGTCCTTGCCGATTC
CXCL 13 TCCAAGGTGTTCTGGAGGTC
CXCL 14 CCCTCCGGTCAGCATGAGImmunohistochemistry staining
Ferrets (n¼3 per group) uninfected or infected with 106 TCID50
of pandemic H1N1 (A/California/07/2009) inﬂuenza virus were
euthanized with high dose of Zoletil at 5 days after infection, and
the left cranial lobes of lungs were collected. The lung tissues were
ﬁxed using 10% neutral-buffered formalin for 24 h and then
embedded in parafﬁn. Five-micrometer sections were made and
stained with mouse inﬂuenza A virus anti-nucleoprotein antibody
(Serotech, United Kingdom). Tissue sections were deparafﬁnized
and hydrated in distilled water. Sections were ﬁxed with 100%
chilled acetone for 2 h for permeabilization, and endogenous
peroxidase activity was blocked by incubating tissue sections in
3% H2O2 for 15 min at 37 1C before the sections were blocked with
5% bovine serum albumin in PBS (pH 7.4) for 1 h. The blocked
tissue sections were labeled with mouse inﬂuenza A virus anti-
nucleoprotein antibody (1:1000 dilution) by incubating at room
temperature for 1 h. The labeled tissue sections were stained with
biotin-labeled goat anti-mouse immunoglobulin (Vector, USA),
VECTASTAIN ABC-AP (Vector, USA), and Vector red alkaline phos-
phatase substrate (Vector, USA). The stained tissue sections were
counterstained with hematoxylin QS (Vector Laboratories, Burlin-
game, CA) before the stained sections were evaluated under an
Olympus DP70 microscope (Olympus Corporation, Tokyo, Japan).
Quantiﬁcation of inﬂammatory cytokines and chemokines by
quantitative real-time PCR
Total RNA was collected from lung tissues (1 g) of ferrets (n¼3
per group) that were infected with 106 TCID50 of 2009 pandemic
H1N1 inﬂuenza virus using TRIzol reagent (Invitrogen, Carlsbad,
CA, USA). cDNA was synthesized using the collected RNAs. SYBR
Green-based real-time PCR was performed using a Roto-Gene
6000 apparatus (Corbett, Mortlake, Australia) and SensiMix Plus
SYBR (Quantace, London, UK) based on the recommendations of
the manufacturer. Samples were run in duplicate. A total volume
of 20 μl containing 2 μl cDNA, 10 μl SYBR mixture, and inﬂamma-
tory cytokine-speciﬁc primers for ferrets (Table 1) or chemokine-
speciﬁc primers for ferrets (Table 2) (Kelvin et al., 2012) [1 μl of
forward primer (20 pmole) and 1 μl of reverse primer (20 pmol)]
was used for 40 cycles of PCR: 5 s at 95 1C, 15 s at 60 1C, and 25 s at
72 1C. Cytokine and toll-like receptor (TLR) expression levels in
tissues were normalized to those of chicken glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). The results of real-time PCR
were quantiﬁed by the comparative threshold method after
subtracting the data from uninfected control ferrets.Reverse primer
GATTCGATAGCCCTCCAGCTT
GAATCTTCCGCAGGGTGTAA
CCCATTTCTTCTGTGGGTTG
GCTTGGGTTTTCTTGTCCAG
ACTGGCTGTTGGTGATCCTC
TATCCTTGGCCAGTTTGGTC
CTTCACCCTCTTGTCCTTGG
TCAGTCCTCTTGCAGCCTTT
ATCTTCACCCAGGGCACTCT
AGCTGGCCCCTACTACCATT
ACTTCCACCTTGGAGCACTG
GGAACAGCGTCTATTCCTCATTG
TC AGCGTGTAGTTCTAGAGAGAGGTACTC
TGGGATTTAGGCATCGTTGT
CCACTTCAATTTCGGGTCAA
GGGAATCTTTCTCTTAAACACTGG
CCAGGCGTTGTACCACTTG
H.M. Kim et al. / Virology 444 (2013) 394–403 403Statistical analysis
Statistical analysis was performed using the Statistical Product
and Services Solutions (SPSS) package, version 10.0 (SPSS, Cary,
NC, USA). The Student's t-test was used. A P-valueo0.05 was
considered to be statistically signiﬁcant.Acknowledgments
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